Teddy Lyons
Teddy comes to KingsCrowd with a background in venture capital and investment banking. He worked at Deutsche Bank as an Investment Banking Analyst in the Technology, Media, and Telecommunications group. Prior to that, he served as an Associate at Alchemi Capital, a venture capital firm in Boston that invests in early-stage technology companies. Teddy holds a degree in Economics and Psychology from Wesleyan University, where he was captain of the varsity soccer team. He is currently enrolled in the M.S. in Finance program at Boston College.
Online Startup Investing in February 2023
Are Founders Single or in a (Co-founding) Relationship?
In honor of Valentine’s Day, this Chart of the Week looks at founders relationships in online startup investing raises between 2020 and 2022.
Gryphon Online Safety Appeals to Internet-Savvy Parents
In a market of bare bones options, Gryphon Online Safety gives parents a comprehensive tool for monitoring their children’s online activity.
FloSpine’s Back Pain Technology Could Be Just What the Doctor Ordered
FloSpine’s technology, KeyLift, is a new, minimally invasive treatment for back pain. But the company’s timeline could pose a risk.
Tbh Brings Celebrity Power to the Chocolate-Hazelnut Spread Market
Tbh -- co-founded by Stranger Things actor Noah Schnapp -- is a selling healthier, vegan alternative to Nutella. But the team may have some growing left to do.
A Toast to the Alcohol Startups of 2022
In this Chart of the Week, we raise a glass to the new year by examining how much funding alcohol and mocktail companies raised in 2022.
20/20 GeneSystems Makes Cancer Screening Affordable
20/20 GeneSystems offers an affordable test that screens for multiple types of cancers. But the market may not be ready for 20/20's solution.
Cusa Tea & Coffee Boasts Rare Differentiation
Cusa Tea & Coffee’s unique botanical extraction process shows a lot of potential. But the company still has more to prove.
Monogram Orthopedics Develops Futuristic Joint Replacement Robots
Monogram Orthopedics is combining 3D printing and robotics for customized joint replacements. It could massively disrupt orthopedic surgery.